BLNC · Balance Labs, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt about the Company's ability to continue as a going concern for a period of twelve months from the date these financial statements were available to be issued.”View the 10-Q filed Aug 14, 2026
Price & Indicators
The closing range uses available history since Dec 19, 2024; less than a full year is stored.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
Versus peers
Consulting Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BLNC
this stock
Balance Labs, Inc.
|
$72.62M | — | +1233.4% | — | 0.0% |
|
VRSK
Verisk Analytics, Inc.
|
$25.66B | -12.4% | +6.6% | 30.1 | 3.2% |
|
EFX
Equifax Inc
|
$21.34B | -16.0% | +6.9% | 29.5 | 4.5% |
|
BAH
Booz Allen Hamilton Holding Corp
|
$9.29B | -7.2% | -6.4% | 12.1 | 5.8% |
|
FCN
Fti Consulting, Inc
|
$4.34B | -8.0% | +2.4% | 19.0 | 11.6% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BLNC | -29.6% | -44.6% | — | -22.5% | +630.4% |
| SPY | +2.6% | -1.1% | +13.4% | -0.4% | +16.0% |
| vs SPY | -32.1% | -43.5% | — | -22.2% | +614.5% |